Bioinova, a.s.

www.bioinova.cz 

Bioinova develops advanced therapy medicinal products (ATMPs) based on stem and other cells obtained and cultured from bone marrow as well as adipose and other tissues. Bioinova is a certified producer of ATMPs and evaluates the developed products in preclinical studies and own clinical trials.

Moreover, combinations of cells with commercially available as well as own biomaterials (including nanomaterials) are evaluated further enhance the efficacy of the ATMPs and opening novel avenues for regenerative medicine and tissue engineering.

The priority of the company is to provide the patients with innovative, safe, efficient and affordable therapeutic methods in various areas of regenerative medicine. To achieve that, great ideas with high-tech equipment as well as hard work and strong partners are combined. Bioinova has established numerous scientific and industrial collaborations with leading academic institutions, hospitals and high-tech companies in the Czech Republic as well as abroad in terms of biomedical research, translational medicine and clinical practice.

Read also

• Institute of Experimental Medicine CAS, Prague
• Institute of Human Genetics, Polish Academy of Sciences
• Institute of Low Temperature and Structure Research, Polish Academy of Sciences
• Centre of Experimental and Clinical Regenerative Medicine
• BIOMIN a.s.
• Vitality Medical & Research Center in the holding of ADONIS Medical Group of Companies
• Petr Vanhara Research Group, Department of Histology and Embryology, Faculty of Medicine, Masaryk University
• Hungary: BioTalentum, Ltd. Gödöllő
• Poland: Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw
• Slovakia: Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava